Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 176   

Articles published

PFE 34.26 +0.46 (1.36%)
price chart
Eye Catching Stock: Pfizer Inc. (NYSE:PFE)
The Company fell -1.79% and finished at $33.97. The daily volume was measured at 43.95 million shares. The 52-week high of the share price is $36.46 and the 52-week low is $28.25.
2 Sizzling Hot Biotechnology Stocks: Pfizer Inc. (PFE), Brookdale Senior ...
Pfizer Inc. (PFE) ended last trading session with a change of -0.81 percent. It trades at an average volume of 38.05M shares versus 25.15M shares recorded at the end of last trading session.
Pfizer Inc. 16% Potential Upside Now Implied by Jefferies
Pfizer Inc. with TICKER NYSE:PFE had its stock rating noted as 'Reiterated' with the recommendation being set at 'BUY' yesterday by analysts at Jefferies.
Pfizer Inc. (PFE) Price Target Lowered Along With Removal From Franchise ...  TCC
Pfizer Inc. (NYSE:PFE) Analyst Opinion  Zergwatch
PFIZER INC. (NYSE:PFE) Financial Condition Compared to S&P 500
This is a financial condition report for PFIZER INC. (NYSE:PFE). In terms of financials, margins and growth we can look at several key indicators and compare the company to the broader S&P 500.
Amgen, Inc. Fits Into Pfizer's Restructuring Plans Perfectly
Pfizer Inc. (NYSE:PFE) is currently considering acting on its plans to reorganize. The drugmaker announced that it would be restructuring itself to focus entirely on some of the key growth businesses, while trimming some of the units.
Pfizer Inc. (PFE) Closes 1.79% Down on the Day for June 24
Pfizer Inc. currently has a total float of 6.06 billion shares and moves 25.27 million a day, on average. The stock opened at $33.80 on June 24 and traded between a low of $33.74 and a high of $34.45.
Pfizer Inc. (NYSE:PFE) topped earnings-per-share estimates 100% of the time
Pfizer Inc. (NYSE:PFE) is expected to announce second quarter financial results before market open (confirmed) on July 26, 2016.
Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), Eye Cannabis Acquisitions
Pharmaceutical giants such as Pfizer Inc. (NYSE:PFE) and Merck & Co., Inc. (NYSE:MRK) are now considering acquisitions in the marijuana industry.
What Wall Street is saying about Pfizer Inc (PFE)  Zergwatch
Summary of Analyst's Study: Pfizer, Inc. (NYSE:PFE) , Spark Therapeutics ...  Street Updates
BRIEF-ICON signed new three-year agreement with Pfizer Inc.
Signed a three-year agreement with Pfizer Inc. * Pfizer has right to extend term for up to an additional two years. * Financial details of agreement were not disclosed.
ICON Reveals Service Deal With Pfizer  Benzinga
ICON Announces Service Agreement with Pfizer  Business Wire (press release)
Germany's Fresenius near deal to buy Pfizer unit
FRANKFURT--German healthcare company Fresenius SE & Co. KGaA (FRE.XE) has a good chance of acquiring Pfizer Inc.'s PFE, -0.50% medical devices arm in a deal that could be announced soon, according to two people familiar with the matter.